IL5 - interleukin 5 Gene

Species: Canis lupus familiaris (sub-species: familiaris)

Gene Type: protein coding
Gene ID: 403790

About IL5

Primary_assembly 11: 21,611,416-21,613,216 reverse strand.ROS_Cfam_1.0:CM025110.1

This gene has 2 transcripts (splice variants) and 91 orthologues.

IL5 Products (1)

mRNA Protein Name
NM_001006950.1 NP_001006951.1 interleukin-5 precursor

IL5 Protein Structure

IL5

IL5: pfam02025 (21 - 132)

  • 0
  • 100
  • 134 a.a.
Protein Preferred Names Protein Names

interleukin-5

  • IL-5

  • T-cell replacing factor

  • TRF

  • eosinophil differentiation factor

  • interleukin 5 (colony-stimulating factor, eosinophil)

Recombinant IL5 Proteins

Cat. No. Product Name Accession Purity
HY-P73218 IL-5 Protein, Canine (sf9, His) Q95J76 (V22-S134) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-17002 Suplatast (Tosilate) Inhibitor 99.67% Unkown
Bioactive MoleculesInhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9945 Mepolizumab 99.4% Unkown
HY-P9923 Benralizumab 99.1% Unkown
HY-P9949 Reslizumab Antagonist 99.4% Unkown

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-111167 AN-2898 Inhibitor / Phase 2
HY-137131 DC-Chol hydrochloride 99.95% Phase 1
Bioactive MoleculesInhibitory Antibodies (7)
Cat. No. Product Name Effect
Purity Phase
HY-P9945A Mepolizumab (anti-IL5) 97.50% Phase 4
HY-P990748 Lunsekimig Inhibitor 99.00% Phase 3
HY-P99850 Depemokimab Inhibitor 95.24% Phase 3
HY-P99371 Lirentelimab Inducer 99.91% Phase 3
HY-P991599 SHR-1703 Inhibitor / Phase 3
HY-P991266 SM-17 Inhibitor 96.98% Phase 2
HY-P991633 TQC2938 Inhibitor / Phase 2

Pre-clinical Phase

Bioactive Molecules (28)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-19969 YM-90709 Inhibitor 99.77% Unkown
HY-N6013 Aloin (mixture of A&B) 99.36% Unkown
HY-NP159 House Dust Mite Extract, from D.farinae Activator / Unkown
HY-N1938 D(+)-Raffinose pentahydrate 98.0% Unkown
HY-N0646 Silydianin 99.71% Unkown
HY-N8309 Luteolin-4'-O-glucoside Inhibitor 99.36% Unkown
HY-P1111 Lyn peptide inhibitor Inhibitor 99.35% Unkown
HY-110295 SPL-334 Inhibitor 99.6% Unkown
HY-19486 UR-1505 Inhibitor 99.97% Unkown
HY-147660 IMMH001 Agonist 98.10% Unkown
HY-W585843 1,1′-Ethylidenebis[L-tryptophan] Activator 96.04% Unkown
HY-106979 Olcorolimus Inhibitor / Unkown
HY-165484 AVP-13358 Inhibitor / Unkown
HY-175876 ADAM17-IN-1 Inhibitor / Unkown
HY-182795 Colchicine derivative-1 / Unkown
HY-19472 RWJ-58643 Inhibitor / Unkown
HY-19472A RWJ-58643 hydrochloride / Unkown
HY-P1111A Lyn peptide inhibitor TFA Inhibitor / Unkown
HY-RS06770 IL5 Human Pre-designed siRNA Set A / Unkown
HY-RS06771 Il5 Mouse Pre-designed siRNA Set A / Unkown
HY-RS06772 Il5 Rat Pre-designed siRNA Set A / Unkown
HY-RS06773 IL5RA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-169864 KRO-105714 Antagonist / Unkown
HY-174601 Human IL5RA mRNA / Unkown
HY-174602 Human IL5 mRNA / Unkown
HY-N6013R Aloin (mixture of A&B) (Standard) / Unkown
HY-RS19696 Il5ra Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26191 Il5ra Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (9)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990774 Verekitug Inhibitor 97.00% Unkown
HY-P9923A Benralizumab (anti-IL5RA ) Inducer 99.60% Unkown
HY-P990213 Anti-Mouse/Human IL-5 Antibody (TRFK5) Inhibitor 97.80% Unkown
HY-P990094 Trabikibart 99.17% Unkown
HY-P990058 Varokibart Inhibitor 95.69% Unkown
HY-P991144 Lasrekibart Ligand 97.056% Unkown
HY-P991712 Revbekitug Inhibitor 96.18% Unkown
HY-P992132 Solaprubart Inhibitor 99.59% Unkown
HY-P990452 Anti-IL-5 Antibody Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens IL5 NCBI NCBI:3567